Ushering in the Golden Era of Alzheimer Drug Development?

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
Related Content

The Week in Review: March 6-10

March 11th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

The Clock-Drawing Test

March 9th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Supporting Those Who Support Us

March 7th 2023

Alzheimer Disease: Are the Treatments Worse Than the Illness?

March 6th 2023

The Week in Review: March 6-10

March 11th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

The Clock-Drawing Test

March 9th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Supporting Those Who Support Us

March 7th 2023

Alzheimer Disease: Are the Treatments Worse Than the Illness?

March 6th 2023

The Week in Review: March 6-10

March 11th 2023

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021

The Clock-Drawing Test

March 9th 2023

The Relevance of New Alzheimer Guidelines for Clinical Practice

August 16th 2012

Supporting Those Who Support Us

March 7th 2023

Alzheimer Disease: Are the Treatments Worse Than the Illness?

March 6th 2023
© 2023 MJH Life Sciences

All rights reserved.